OpenLB
Open Library of Bioscience
Advanced Search
Journal of cellular and molecular medicine
Nov, 2024;28 (22): e70201.

Study on the mechanism of Shenmai injection in the treatment of sepsis.

Mengxia Yang, Tengfei Chen, Yue Xu, Qingquan Liu, Xiaolong Xu
Author Information
  1. Mengxia Yang: Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China. ORCID
  2. Tengfei Chen: Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
  3. Yue Xu: China Science and Technology Development Center for Chinese Medicine, Beijing, China.
  4. Qingquan Liu: Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
  5. Xiaolong Xu: Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
PMID: 39584444 DOI: 10.1111/jcmm.70201

Abstract

Shenmai injection (SMI) is widely used in the clinical treatment of sepsis, but its mechanism is not yet clear. This study aimed to explore the molecular mechanism through network pharmacology, bioinformatics, and molecular docking technologies. The active ingredients and targets of SMI were screened through traditional Chinese medicine databases and the Swiss Target Prediction database, respectively. The disease genes were searched using GEO and GeneCards databases, and Venn mapping was used to screen potential therapeutic targets. The key targets were selected using Cytoscape 3.9.1 software. The BioGPS database was used to evaluate the expression of these targets in tissues/cells. The DAVID database is used for enrichment analysis. Molecular docking technology was used to evaluate the interaction between these targets and core active ingredients. 122 potential therapeutic targets and 28 key targets were identified. Forty-six potential therapeutic targets showed highly specific expression in 40 tissues/cells. The PI3K-AKT, RAP1, and MAPK signalling pathways are highly enriched. The molecular docking results showed good interactions. This study systematically analysed the mechanism of SMI in treating sepsis, involving multiple targets and pathways, possibly related to anti-inflammatory, anti-oxidative stress, and immune regulation, providing reference value for future basic research of sepsis.

Keywords

Shenmai injection bioinformatics mechanism molecular docking network pharmacology sepsis

References

  1. Pharm Biol. 2020 Dec;58(1):72-79 [PMID: 31875760]
  2. Nucleic Acids Res. 2022 Jul 5;50(W1):W216-W221 [PMID: 35325185]
  3. Shock. 2005 Jul;24(1):40-7 [PMID: 15988319]
  4. Biomed Pharmacother. 2019 Dec;120:109231 [PMID: 31546082]
  5. J Mol Cell Cardiol. 2023 Jul;180:58-68 [PMID: 37172930]
  6. Discov Med. 2023 Dec;35(179):946-955 [PMID: 38058059]
  7. BMC Syst Biol. 2014;8 Suppl 4:S11 [PMID: 25521941]
  8. Phytomedicine. 2023 Sep;118:154938 [PMID: 37406390]
  9. Neurochem Res. 2016 May;41(5):951-7 [PMID: 26738987]
  10. Curr Protoc Bioinformatics. 2016 Jun 20;54:1.30.1-1.30.33 [PMID: 27322403]
  11. Front Endocrinol (Lausanne). 2020 Mar 06;11:104 [PMID: 32210915]
  12. JAMA. 2016 Feb 23;315(8):801-10 [PMID: 26903338]
  13. J Ethnopharmacol. 2023 Jun 12;309:116306 [PMID: 36858276]
  14. Nucleic Acids Res. 2023 Jan 6;51(D1):D1373-D1380 [PMID: 36305812]
  15. Heliyon. 2023 Nov 15;9(11):e22290 [PMID: 38045180]
  16. Theranostics. 2022 Jan 1;12(2):976-998 [PMID: 34976224]
  17. Biomed Res Int. 2021 Apr 29;2021:5535562 [PMID: 33997001]
  18. Chem Biol Interact. 2015 Jun 25;235:56-62 [PMID: 25843058]
  19. Food Chem Toxicol. 2021 Dec;158:112696 [PMID: 34822940]
  20. Redox Biol. 2021 May;41:101954 [PMID: 33774474]
  21. J Glob Antimicrob Resist. 2017 Sep;10:204-212 [PMID: 28743646]
  22. Pharm Biol. 2022 Dec;60(1):543-552 [PMID: 35225146]
  23. Chem Biol Interact. 2022 Sep 25;365:110117 [PMID: 35995256]
  24. Biomed Pharmacother. 2022 Sep;153:113317 [PMID: 35772378]
  25. J Neuroinflammation. 2022 Nov 4;19(1):268 [PMID: 36333747]
  26. Infect Drug Resist. 2022 Dec 23;15:7667-7678 [PMID: 36582454]
  27. Cell Death Dis. 2022 Nov 7;13(11):934 [PMID: 36344490]
  28. Mol Med. 2023 Jun 20;29(1):76 [PMID: 37340376]
  29. Int J Cancer. 2009 Dec 15;125(12):2863-70 [PMID: 19609947]
  30. Chin Med. 2022 Feb 5;17(1):19 [PMID: 35123524]
  31. J Biosci Bioeng. 2022 Nov;134(5):363-373 [PMID: 36127250]
  32. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Nov;31(11):1317-1323 [PMID: 31898559]
  33. Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5 [PMID: 23193258]
  34. Int J Mol Sci. 2021 Oct 14;22(20): [PMID: 34681737]
  35. Nucleic Acids Res. 2023 Jan 6;51(D1):D638-D646 [PMID: 36370105]
  36. Nucleic Acids Res. 2016 Jan 4;44(D1):D313-6 [PMID: 26578587]
  37. Genome Res. 2003 Nov;13(11):2498-504 [PMID: 14597658]
  38. Crit Care Med. 2021 Nov 1;49(11):e1063-e1143 [PMID: 34605781]
  39. Br J Pharmacol. 2006 Dec;149(8):1092-103 [PMID: 17088869]
  40. Nucleic Acids Res. 2019 Jul 2;47(W1):W357-W364 [PMID: 31106366]
  41. Mol Biol Rep. 2022 Oct;49(10):9767-9781 [PMID: 35499687]
  42. Lab Invest. 2019 Dec;99(12):1795-1809 [PMID: 31570770]
  43. PLoS One. 2011 Jan 06;6(1):e15939 [PMID: 21253603]
  44. Food Chem Toxicol. 2019 Aug;130:130-141 [PMID: 31103739]
  45. Mol Immunol. 2022 Jan;141:318-327 [PMID: 34952420]
  46. Fundam Clin Pharmacol. 2015 Oct;29(5):462-71 [PMID: 26211495]
  47. Pol Arch Intern Med. 2022 Aug 22;132(7-8): [PMID: 35791800]
  48. Expert Rev Anti Infect Ther. 2012 Jun;10(6):701-6 [PMID: 22734959]
  49. Phytomedicine. 2023 May;113:154728 [PMID: 36898255]
  50. Intensive Care Med. 2022 Dec;48(12):1799-1802 [PMID: 36102944]
  51. Int Immunopharmacol. 2023 Jul;120:110375 [PMID: 37267857]
  52. J Cheminform. 2014 Apr 16;6:13 [PMID: 24735618]
  53. Front Immunol. 2022 Dec 01;13:1018973 [PMID: 36532047]
  54. J Immunotoxicol. 2014 Jul-Sep;11(3):231-7 [PMID: 23971717]
  55. Neurosci Lett. 2012 Apr 4;513(2):229-32 [PMID: 22387154]
  56. SAGE Open Med. 2019 Mar 21;7:2050312119835043 [PMID: 30915218]
  57. Front Pharmacol. 2022 Mar 15;13:830030 [PMID: 35370733]

Grants

  1. 82474428/National Natural Science Foundation of China
  2. ZYYCXTD-D-202201/National Multidisciplinary Innovation Team Project of Traditional Chinese Medicine
  3. zyyzdxk-2023001/State Administration of Traditional Chinese Medicine

MeSH Term

Drugs, Chinese Herbal
Sepsis
Molecular Docking Simulation
Humans
Drug Combinations
Computational Biology
Signal Transduction
Medicine, Chinese Traditional
Network Pharmacology
Injections

Chemicals

Drugs, Chinese Herbal
fructus schizandrae, radix ginseng, radix ophiopogonis drug combination
Drug Combinations
Journal Article

Word Cloud

Created with Highcharts 10.0.0targetsusedsepsismechanismmoleculardockingShenmaiinjectionSMIdatabasepotentialtherapeutictreatmentstudynetworkpharmacologybioinformaticsactiveingredientsdatabasesusingkeyevaluateexpressiontissues/cellsshowedhighlypathwayswidelyclinicalyetclearaimedexploretechnologiesscreenedtraditionalChinesemedicineSwissTargetPredictionrespectivelydiseasegenessearchedGEOGeneCardsVennmappingscreenselectedCytoscape391softwareBioGPSDAVIDenrichmentanalysisMoleculartechnologyinteractioncore12228identifiedForty-sixspecific40PI3K-AKTRAP1MAPKsignallingenrichedresultsgoodinteractionssystematicallyanalysedtreatinginvolvingmultiplepossiblyrelatedanti-inflammatoryanti-oxidativestressimmuneregulationprovidingreferencevaluefuturebasicresearchStudy

Similar Articles

Cited By